Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
Résultats de la recherche
Tout
Rechercher les filtres
-
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
-
Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure
-
DAVOS, Switzerland, Jan. 27, 2025 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s (UsA2), the Davos Alzheimer's Collaborative (DAC) and the McKinsey Health Institute (MHI) teamed up to identify the most...
-
New educational tool will help companies assess how well their health and well-being programs support their workforce’s brain health, a critical factor in employees’ overall health, performance and...
-
WASHINGTON, April 16, 2024 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s today announced the return of its Brain Health Academy, scheduled to begin on May 9, 2024. First launched in 2022, the Academy...
-
Congress passes major investments in the fight against Alzheimer’s.
-
WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...
-
Washington, DC, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Today, UsAgainstAlzheimer’s, along with collaborators AARP, GN Group, Eli Lilly, and Novo Nordisk, launched the Business Collaborative for Brain...
-
Washington, DC, Oct. 20, 2023 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s this week hosted the 2023 National Alzheimer’s Summit, a groundbreaking event dedicated to applying recent scientific and...
-
Washington, DC, July 06, 2023 (GLOBE NEWSWIRE) -- Patient advocacy organization UsAgainstAlzheimer’s today hailed the first-of-its-kind traditional approval by the Food and Drug Administration (FDA)...